- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 509529, 3 pages
The Effects of SIRT1 on Alzheimer's Disease Models
Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA
Received 2 July 2012; Accepted 20 November 2012
Academic Editor: Francesco Panza
Copyright © 2012 Gizem Donmez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. Donmez, “The neurobiology of sirtuins and their role in neurodegeneration,” Trends in Pharmacological Sciences, vol. 33, no. 9, pp. 494–501, 2012.
- D. Selkoe, “Images in Neuroscience. Alzheimer's disease: from genes to pathogenesis,” American Journal of Psychiatry, vol. 154, no. 9, p. 1198, 1997.
- L. Bertram and R. E. Tanzi, “The genetic epidemiology of neurodegenerative disease,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1449–1457, 2005.
- B. De Strooper, “Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease,” EMBO Reports, vol. 8, no. 2, pp. 141–146, 2007.
- R. Postina, A. Schroeder, I. Dewachter et al., “A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alheizmer disease mouse model,” Journal of Clinical Investigation, vol. 113, no. 10, pp. 1456–1464, 2004.
- M. P. Mattson, “Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives,” Physiological Reviews, vol. 77, no. 4, pp. 1081–1132, 1997.
- E. Kojro and F. Fahrenholz, “The non-amyloidogenic pathway: structure and function of alpha-secretases,” Sub-Cellular Biochemistry, vol. 38, pp. 105–127, 2005.
- J. L. Jankowsky, D. J. Fadale, J. Anderson et al., “Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase,” Human Molecular Genetics, vol. 13, no. 2, pp. 159–170, 2004.
- T. Malm, J. Koistinaho, and K. Kanninen, “Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 517160, 2011.
- G. Donmez, D. Wang, D. E. Cohen, and L. Guarente, “SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10,” Cell, vol. 23, no. 142, pp. 320–332, 2010.
- W. Qin, M. Chachich, M. Lane, et al., “Calorie restriction attenuates Alzheimer’s disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus),” Journal of Alzheimer's Disease, vol. 10, pp. 417–422, 2006.
- J. Chen, Y. Zhou, S. Mueller-Steiner et al., “SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling,” Journal of Biological Chemistry, vol. 280, no. 48, pp. 40364–40374, 2005.
- C. Julien, C. Tremblay, V. Émond et al., “Sirtuin 1 reduction parallels the accumulation of tau in alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 68, no. 1, pp. 48–58, 2009.
- S. W. Min, S. H. Cho, Y. Zhou et al., “Acetylation of tau inhibits its degradation and contributes to tauopathy,” Neuron, vol. 67, no. 6, pp. 953–966, 2010.
- Y. Yoshiyama, M. Higuchi, B. Zhang et al., “Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model,” Neuron, vol. 53, no. 3, pp. 337–351, 2007.
- P. McMillan, E. Korvatska, P. Poorkaj et al., “Tau isoform regulation is region- and cell-specific in mouse brain,” Journal of Comparative Neurology, vol. 511, no. 6, pp. 788–803, 2008.
- J. C. Cruz, H. C. Tseng, J. A. Goldman, H. Shih, and L. H. Tsai, “Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles,” Neuron, vol. 40, no. 3, pp. 471–483, 2003.
- D. Kim, M. D. Nguyen, M. M. Dobbin et al., “SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis,” EMBO Journal, vol. 26, no. 13, pp. 3169–3179, 2007.
- S. Helisalmi, S. Vepsäläinen, M. Hiltunen et al., “Genetic study between SIRT1, PPARD, PGC-1α genes and Alzheimer's disease,” Journal of Neurology, vol. 255, no. 5, pp. 668–673, 2008.